About this trial
Primary objective:
\- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope.
Secondary objectives:
* To measure the reproducibility of assessments; * To evaluate the detection of progressive changes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
100 subjects aged 10 to 79 years with a condition that may affect the inner retina (e.g., glaucoma, optic neuropathy, etc.)
100 subjects aged 10 to 80 years with a condition that may affect the outer retina (e.g., AMD, retinitis pigmentosa, etc.)
Male or female
Covered by health insurance
Disqualifiers
Inability to remain motionless on a standard ophthalmic chin rest. RETION_Protocol_v2.0 dated June 10, 2026_IDRCB: 2026-A00324-47 Page 10 of 44
Subjects taking medications or suffering from a medical condition that could interfere with the evaluations planned under the protocol;
Participants allergic to tropicamide in cases where pupil dilation is required. ☞ Wearing glasses or contact lenses to correct a refractive error is not considered an exclusion criterion.
Trial design
Single group
Treatments tested in this trial
MONA Imaging System
Deviceacquisition mode with mona system
Treatment groups
Trial outcomes
Primary outcomes
Proportion of images obtained with the MONA system deemed usable for the analysis of retinal microstructures.
Images are considered usable if they allow for: * visualization of retinal microstructures (yes/no); * measurement of cell density (yes/no); * measurement of vascular diameter (yes/no).
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: